News Home

Is Autolus Therapeutics PLC (AUTL) a Good Choice in Biotechnology Friday?

Friday, June 02, 2023 02:54 PM | InvestorsObserver Analysts

Mentioned in this article

Is Autolus Therapeutics PLC (AUTL) a Good Choice in Biotechnology Friday?

Autolus Therapeutics PLC (AUTL) is around the top of the Biotechnology industry according to InvestorsObserver. AUTL received an overall rating of 87, which means that it scores higher than 87 percent of all stocks. Autolus Therapeutics PLC also achieved a score of 97 in the Biotechnology industry, putting it above 97 percent of Biotechnology stocks. Biotechnology is ranked 13 out of the 148 industries.

Overall Score - 87
AUTL has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on AUTL!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 87 would rank higher than 87 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Autolus Therapeutics PLC Stock Today?

Autolus Therapeutics PLC (AUTL) stock is down -7.83% while the S&P 500 is higher by 1.54% as of 2:41 PM on Friday, Jun 2. AUTL has fallen -$0.25 from the previous closing price of $3.13 on volume of 1,652,814 shares. Over the past year the S&P 500 is up 2.61% while AUTL is higher by 12.89%. AUTL lost -$1.41 per share the over the last 12 months. Click Here to get the full Stock Report for Autolus Therapeutics PLC stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App